SOURCE: Solos Endoscopy, Inc.

February 13, 2007 10:31 ET

Solos Endoscopy, Inc. Board of Directors Approves Acquisition and Merger Strategy

BOSTON, MA -- (MARKET WIRE) -- February 13, 2007 -- Solos Endoscopy, Inc. (PINKSHEETS: SLSY) is pleased to announce that the Company's board of directors has approved a new acquisition and merger strategy. Solos Endoscopy is currently considering several companies in the endoscopic medical industry. The Company will look to expand their presence throughout the country while constantly increasing their market share.

The global market for minimally invasive surgery, or endoscopic, devices and instruments was worth an estimated $12 billion in 2005, and is expected to reach $12.9 billion in 2006 and $18.5 billion by 2011. This represents an average annual growth rate of 7.5% between 2006 and 2011. Solos Endoscopy intends to obtain a larger portion of this market by increasing its product catalogue, as well as its distribution channels through its new acquisition and merger strategy.

"Our strategy through mergers and acquisitions is to continue offering top-of-the-line medical products while developing innovative new devices and increasing our presence in the endoscopic market," stated Bob Segersten, President of Solos Endoscopy, Inc.

Solos Endoscopy, Inc. recently announced that the Company has received orders for the Solos Breast Endoscopy System. The Company recently launched their new Solos Breast Endoscopy System and has received positive feedback from doctors throughout the country. Solos Endoscopy has received numerous requests and shipped several systems to hospitals around the U.S. for product evaluation.

About Solos Endoscopy, Inc.:

Solos Endoscopy, Inc. is a healthcare technology company whose mission is to develop and market breakthrough technology, applications, medical devices, and procedural techniques for the screening, diagnosis, treatment and management of medical conditions. Backed by technical support, Solos' sales team can help make the right buying decisions for the hospital, surgery center, or physician office. Additional information is available on the Company's website at: www.solosendoscopy.com.

Safe Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.

To automatically receive instant updates, press releases, and other information on this and other Big Apple Consulting USA companies, please visit www.bigappleconsulting.com/compro.php and download your FREE copy of Big Apple ComPro.

Contact Information